Tony ???

Prof Tony Cunningham AO

Infectious Diseases Physician; Director, Centre for Virus Research at The Westmead Institute for Medical Research
Professor Anthony Cunningham AO, FAHMS, MD, FRACP, FRCPA is an infectious diseases physician, clinical virologist and scientist. He is Director, Centre for Virus Research at The Westmead Institute for Medical Research (WIMR); Director, Australian Centre for HIV and Hepatitis Virology Research (ACH2); and Professor in the Faculty of Medicine and Health at the University of Sydney. Tony built up the NSW State Reference Laboratory in Virology in the mid-1980s before assuming directorship of WIMR in 1996. He was awarded Officer of the Order of Australia (AO) in 2010 for ‘service to medicine, particularly in the field of viral research and through the development of leadership of medical and biomedical research’, and in 2015, was elected as an inaugural Fellow of the Australian Academy of Health and Medical Sciences. Tony is the lead author of the ‘Vaccines for COVID-19’ paper, commissioned from the Australian Academy of Health and Medical Sciences and is a longstanding consultant for Seqirus, Merck and GSK on vaccines in the ageing and for shingles and herpes. Since stepping down from the WIMR director role, he has continued his research on a NHMRC Senior Investigator Grant and become immersed in COVID-19 research, amongst other advisory positions including the NSW COVID Vaccines Committee.

More from this expert

Monographs iconMonographs

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

Videos iconVideos

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

Videos iconVideos

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

Monographs iconMonographs

New and important vaccine for Herpes Zoster prevention is now available in Australia.

Podcasts iconPodcasts

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

Videos iconVideos

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

Podcasts iconPodcasts

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

Videos iconVideos

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

Podcasts iconPodcasts

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Videos iconVideos